Anticholinesterases induce multigenic transcriptional feedback response suppressing cholinergic neurotransmission

Chemico-Biological Interactions

Volumn 119-120, Issue , 1999, Pages 349-360

  Kaufer, Daniela ^a   Friedman, Alon ^a,b   Seidman, Shlomo ^a   Soreq, Hermona ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Anticholinesterases; Cholinergic neurotransmission suppression; Induced multigenic transcription

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; CHOLINE ACETYLTRANSFERASE; CHOLINESTERASE INHIBITOR; DYFLOS; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; PHYSOSTIGMINE; PYRIDOSTIGMINE; SYNAPTOPHYSIN; TETRODOTOXIN; VESICULAR ACETYLCHOLINE TRANSPORTER;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; BRAIN SLICE; CHOLINERGIC TRANSMISSION; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS; TRANSCRIPTION REGULATION;

ACETYLCHOLINESTERASE; ANIMALS; BRAIN; CARRIER PROTEINS; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; CHOLINESTERASE INHIBITORS; FEEDBACK; GENE EXPRESSION REGULATION; MEMBRANE TRANSPORT PROTEINS; MICE; NEURAL INHIBITION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STRESS; SYNAPTIC TRANSMISSION; TRANSCRIPTION, GENETIC; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS; VESICULAR TRANSPORT PROTEINS;

EID: 0033063505     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(99)00046-0     Document Type: Conference Paper

References (42)

1. Soreq H., Zakut H. Human Cholinesterases and Anticholinesterases. 1993;1-300 Academic Press, San Diego.
2. Schwarz M., Loewenstein-Lichtenstein Y., Glick D., Liao J., Norgaard-Pedersen B., Soreq H. Successive organophosphate inhibition and oxime reactivation reveals distinct responses of recombinant human cholinesterase variants. Molec. Brain Res. 31:1995;101-110.
3. Sheets L.P., Hamilton B.F., Sangha G.K., Thyssen J.H. Subchronic neurotoxicity screening studies with six organophosphate insecticides: an assessment of behavior and morphology relative to cholinesterase inhibition. Fundam. Appl. Toxicol. 35:1997;101-119.
4. Prendergast M.A., Terry A.V., Buccafusco J.J Chronic low-level exposure to DFP causes protracted impairment of spatial navigation learning. Psychopharmacol. Berl. 129:1997;183-191.
5. Stroller A., Krupinski J., Christophers A.J., Blanks A.K Organophosphorus insecticide and major mental ilness. Lancet. 1:1965;1387-1388.
6. Tabershaw I.R., Cooper W.C Sequelae of acute organic phosphate poisoning. J. Occup. Med. 8:1966;5-10.
7. Clark G. Organophosphate insecticides and behaviour: a review. Aerospace Med. 42:1971;735-740.
8. Savage E.P., Keefe T.J., Mounce L.M., Heaton R.K., Lewin J.A., Burcar P.J Chronic neurological sequelae of acute organophosphate pesticide poisoning. Arch. Environ. Health. 43:1988;38-45.
9. Rosenstock L., Keifer M., Daniell W.E., McConnell R., Claypoole K. Chronic central nervous system effects of acute organophosphate pesticide intoxication. Lancet. 338:1991;223-227.
10. McLeod C.G., Singer A.W., Harrington D.G Acute neuropathology in soman poisoned rats. Neurotoxicology. 5:1984;53-57.
11. Marrosu F., Pinna A., Fadda P., Fratta W., Morelli M. C-Fos expression as a molecular marker in corticotropin-releasing factor-induced seizures. Synapse. 24:1996;297-304.
12. Gass P., Bruehl C., Herdegen T., Kiessling M., Lutzenburg M., Witte O.W. Induction of FOS and JUN proteins during focal epilepsy: congruences with and differences to [14C]deoxyglucose metabolism. Brain-Res-Mol-Brain-Res. 46:1997;177-184.
13. Buccafusco J.J., Prendergast M.A., Pauly J.R., Terry A.V., Goldstein B.D., Shuster L.C. A rat model for gulf war illness-related selective memory impairment and the loss of hipocampal nicotinic receptors. Soc. Neurosci. 23:1997;19-90.
14. Wickelgr I. The big easy serves up a feast to visiting neuroscientists: rat model for Gulf War syndrome? Science. 278:1998;1404.
15. Friedman A., Kaufer D., Shemer J., Hendler I., Soreq H., Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat. Med. 2:1996;1382-1385.
16. Kaufer D., Friedman A., Seidman S., Soreq H. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature. 393:1998;373-376.
17. Friedman A., Gutnick M.J. Intracellular calcium and control of burst generation in neurons of guinea-pig neocortex in vitro. Eur. J. Neurosci. 1:1989;374-381.
18. Gutnick M.J., Friedman A. Synaptic and intrinsic mechanisms of synchronization and epileptogenesis in the neocortex. Exp. Brain Res. Suppl. 14:1986;327-335.
19. Ben Aziz-Aloya R., Seidman S., Timberg R., Sternfeld M., Zakut H., Soreq H. Expression of a human acetylcholinesterase promoter-reporter construct in developing neuromuscular junctions of Xenopus embryos. Proc. Natl. Acad. Sci. USA. 90:1993;2471-2475.
20. Li Y., Camp S., Rachinsky T.L., Bongiorno C., Taylor P. Promoter elements and transcriptional control of the mouse acetylcholinesterase gene. J. Biol. Chem. 268:1993;3563-3572.
21. Bausero P., Schmitt M., Toussaint J.L. et al. Identification and analysis of the human choline acetyltransferase gene promoter. Neuroreport. 4:1993;287-290.
22. Cervini R., Houhou P.F., Pradat S., Bejanin J., Mallet S., Berrard Specific vesicular acetylcholine transporter promoters lie within the first intron of the rat choline acetyltransferase gene. J. Biol. Chem. 270:1995;2465-2467.
23. Ghosh A., Ginty D.D., Bading H., Greenberg M.E. Calcium regulation of gene expression in neuronal cells. J. Neurobiol. 25:1994;294-303.
24. Laskowski M.B., Dettbarn W.D. Presynaptic effects of neuromuscular acetylcholinesterase inhibition. J. Pharmacol. Exp. Ther. 194:1975;351-361.
25. Bakry N.M., El-Rashidy A.H., Eldefrawi A.T., Eldefrawi M.E. Direct actions of organophosphate anticholinesterases on nicotinic and muscarinic acetylcholine receptors. J. Biochem. Toxicol. 3:1988;235-239.
26. Idriss M.K., Aguayo L.G., Rickett D.L., Albuquerque E.X. Organophasphate and carabamate compounds have pre- and post-junctional effects at the insect glutamatergic synapse. J. Pharmacol. Exp. Ther. 239:1986;279-285.
27. + in blockade of the N-methyl-D-aspartate receptor channel. Mol. Pharmacol. 46:1994;151-160.
28. Rocha E.S., Aracava Y., Albuquerque E.X. GABAA receptors as a target for paraoxon-induced toxicity in mammalian neurons. Toxcicologist. 15:1995;207.
29. De La Escalera S., Bockmap E.O., Moya F., Piovant M., Jimenez F. Characterization and gene cloning of Neurotactin, a Drosophila transmembrane protein related to cholinesterases. EMBO J. 9:1990;3593-3601.
30. Auld V.J., Fetter R.D., Broadie K., Goodman C.S. Gliotactin, a novel transmembrane protein on peripheral glia, is required to form the blood-nerve barrier in Drosophila. Cell. 81:1995;757-767.
31. Ichtchenko K., Nguyen T., Sudhof T.C. Structures, alternative splicing, and neurexin binding of multiple neuroligins. J. Biol. Chem. 271:1996;2676-2682.
32. Songyang Z., Fanning A.S., Fu C., Xu J., Marafatia S.M., Chishti A.H., Crompton A., Chan A.C., Anderson J.M., Cantley L.C. Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science. 275:1997;73-77.
33. Irie M., Hata Y., Takeuchi M., Ichtchenko K., Toyoda A., Hirao K., Takai Y., Rosahl T.W., Sudhof T.C. Binding of neuroligins to PSD-95. Science. 277:1997;1511-1515.
34. Darboux I., Barthalay Y., Piovant M., Hipeau-Jacqoutte R. The structure-function relationships in Drosophila Neurotactin show that cholinesterasic domains may have adhesive properties. EMBO J. 15:1996;4835-4843.
35. Gurvitz T.V., Lasko N.B., Schachter S.C., Kuhne A.A., Orr S.P., Pitman R.K. Neurological status of Vietnam veterans with chronic post-traumatic stress disorder. J. Neuropsychiatry Clin. Neurosci. 5:1993;183-188.
36. Sapolsky R.M. Why stress is bad for your brain. Science. 273:1996;749-750.
37. Metcalf D.R., Holmes J.H. VII. Toxicology and physiology. EEG, psychological, and neurological alterations in humans with organophosphorus exposure. Ann. NY Acad. Sci. 160:1969;357-365.
38. Levin H.S., Rodnitzky R.L. Behavioral effects of organophosphate in man. ClinToxicol. 9:1976;391-403.
39. Beeri R., Andres C., Lev-Lehman E., Timberg R., Huberman T., Shani M., Soreq H. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr. Biol. 5:1995;1063-1071.
40. Beeri R., LeNovere N., Mervis R., Huberman T., Grauer E., Changeux J.P., Soreq H. Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired ACHE-transgenic mice. J. Neurochem. 69:1997;2441-2451.
41. Rider J.A., Ellinwood L.E., Coon J.M. Production of tolerance in the rat to octamethyl pyrophosphoramide (OMPA). Proc. Soc. Exp. Biol. Med. 81:1952;455-460.
42. Russell R.W., Varbutrun D.M., Segal D.S. Behavioral tolerance during chronic changes in the cholinergic system. Commun. Behav. Biol. 4:1969;121-128.